Intelligent Hearing Systems Corp

Intelligent Hearing Systems Corp, a Miami-based small business manufacturer and for-profit corporation, specializes in providing advanced auditory and vestibular diagnostic equipment to federal agencies. The company designs, manufactures, and delivers specialized hearing assessment systems and related software solutions to support medical diagnostics, research, and clinical applications across the federal government. Since its registration in SAM.gov in July 2001, Intelligent Hearing Systems has established itself as a key supplier of innovative hearing testing technologies to multiple federal departments and agencies, including the Department of Veterans Affairs, Department of Defense, and National Institutes of Health.

Through its federal contract awards, Intelligent Hearing Systems has primarily furnished purchase orders for brand-specific auditory diagnostic systems and related equipment. The company's contract portfolio demonstrates a strong focus on delivering DUET systems, SMARTEP systems, and auditory evoked potential (AEP) and otoacoustic emissions (OAE) testing platforms. Recent contract awards include a $30.5 million firm fixed-price purchase order from the Department of Veterans Affairs Veterans Integrated Service Network 7 for an Auditory Evoked Potential System with advanced diagnostic capabilities such as electrocochleography, auditory brainstem response, and cervical and ocular vestibular evoked myogenic potential testing. Other significant contracts awarded include a $23,055 contract from the U.S. Navy's Bureau of Medicine and Surgery for a DUET 2 Channel AEP System, a $26,635 contract from Veterans Integrated Service Network 4 for a DUET ABR system, and multiple contracts from the National Institute on Deafness and Other Communication Disorders (NIDCD) ranging from $15,000 to $24,082.50 for expanding auditory assessment capabilities and providing programming support for customized testing protocols. The company has also received contracts from the National Institute of Diabetes and Digestive and Kidney Diseases, the U.S. Air Force, and the Office of Logistics and Acquisition Operations. Contract awards typically feature firm fixed-price arrangements with completion dates between six months to one year. Most recent contracts do not utilize small business set-aside designations, though earlier awards include Total Small Business Set-Aside contracts, indicating the company's status as a qualifying small business. The company performs substantially all work in-house from its Miami headquarters without significant subcontracting arrangements.

Through federal grant awards, Intelligent Hearing Systems has partnered with the National Institute on Deafness and Other Communication Disorders (NIDCD) to advance auditory diagnostic technology through research and development initiatives. Most recently, the company received a $308,712 project grant from NIDCD under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) with a performance period from May 1, 2025 to April 30, 2026. This grant supports the development of an efficient automated Auditory Brainstem Response (ABR) testing system incorporating artificial intelligence for telemedicine applications in hearing screening and diagnosis, with the goal of improving accessibility and accuracy of auditory evoked response testing, particularly for young patients. The grant involves collaboration with the University of Washington to integrate an AI-based algorithm with Intelligent Hearing Systems' cost-effective hardware platform and will utilize clinical ABR test session data from Seattle Children's Hospital to improve ABR threshold estimation and overall system performance. The company previously received a project grant from NIDCD with an award date of June 10, 2024 and completion date of May 31, 2025 to develop a commercial device for assessing eighth nerve function and cochlear implant candidacy using electrically evoked auditory brainstem responses (EEABR) with direct promontory stimulation. This device development project focuses on creating a compact and portable system with innovative amplifier hardware design, integrated electrical stimulation circuitry, and associated shielded disposable electrodes, with Phase I testing conducted through animal experiments to demonstrate device effectiveness.